CHI HEALTH MISSOURI VALLEY — Hospital Ledger

45 CFR § 180 compliance

A · 100

This hospital published most of what § 180 requires.

●Machine-readable file published

●Gross / standard charges

●Discounted cash price

●Payer-specific negotiated rates

●Min / max negotiated charges

●Free, public, no login required

Procedures listed

11,000

Insurances with rates

CPT / HCPCS codes

7,408

Source MRF

json ↗

Most expensive procedures (gross)

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J0225	VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE	$596,755	$292,410	$340,150	$584,820	21
J0225	VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE	$596,755	$292,410	$208,864	$584,820	31
A9513	LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION	$237,500	$116,375	$135,375	$232,750	21
A9513	LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION	$237,500	$116,375	$279	$232,750	33
J1823	INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION	$218,333	$106,983	$124,450	$213,966	21
J1823	INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION	$218,333	$106,983	$474	$213,966	33
J2351	OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN	$206,410	$101,141	$117,653	$202,281	21
J2351	OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN	$206,410	$101,141	$72,243	$202,281	31
C9293	GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION	$205,870	$100,876	$117,346	$201,753	21
C9293	GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION	$205,870	$100,876	$385	$201,753	33
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$177,544	$86,996	$101,200	$173,993	21
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$177,544	$86,996	$189	$173,993	33
J1747	SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION	$127,833	$62,638	$72,865	$125,276	21
J1747	SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION	$127,833	$62,638	$44,741	$125,276	31
J2327	RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE	$108,000	$52,920	$61,560	$105,840	21
J2327	RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE	$108,000	$52,920	$37,800	$105,840	31
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$98,572	$48,300	$56,186	$96,600	21
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$98,572	$48,300	$58.76	$96,600	33
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$90,347	$44,270	$51,498	$88,540	21
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$90,347	$44,270	$136	$88,540	33
J0638	CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION	$85,619	$41,953	$48,803	$83,906	21
J0638	CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION	$85,619	$41,953	$124	$83,906	33
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN	$78,865	$38,644	$44,953	$77,288	21
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN	$78,865	$38,644	$27,603	$77,288	31
J3241	TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION	$77,358	$37,905	$44,094	$75,811	21
J3241	TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION	$77,358	$37,905	$333	$75,811	33
J2507	PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION	$76,930	$37,696	$43,850	$75,391	21
J2507	PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION	$76,930	$37,696	$3,392	$75,391	33
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$72,662	$35,605	$41,418	$71,209	21
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$72,662	$35,605	$25,432	$71,209	31
J1628	GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE	$70,283	$34,439	$40,061	$68,877	21
J1628	GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE	$70,283	$34,439	$139	$68,877	33
J3245	TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE	$66,589	$32,629	$37,956	$65,257	21
J3245	TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE	$66,589	$32,629	$140	$65,257	33
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION	$60,477	$29,634	$34,472	$59,268	21
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION	$60,477	$29,634	$153	$59,268	33
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$58,710	$28,768	$33,465	$57,536	21
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$58,710	$28,768	$253	$57,536	33
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$56,682	$27,774	$32,309	$55,548	21
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$56,682	$27,774	$19,839	$55,548	31
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$56,456	$27,664	$32,180	$55,327	21
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$56,456	$27,664	$232	$55,327	33
J9022	ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$56,259	$27,567	$32,068	$55,134	21
J9022	ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$56,259	$27,567	$91.86	$55,134	33
J1640	HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION	$54,702	$26,804	$31,180	$53,608	21
J1640	HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION	$54,702	$26,804	$31.35	$53,608	33
J9144	DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN	$52,595	$25,772	$29,979	$51,543	21
J9144	DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN	$52,595	$25,772	$53.4	$51,543	33
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$52,363	$25,658	$29,847	$51,315	21
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$52,363	$25,658	$18,327	$51,315	31

Showing top 50 of 11,000 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.